Responding to the Ever-Changing Needs in Healthcare with Consistent Access to Medicines

Kent-Athlone Pharma Group's CEO, Terry Petersen, discusses the company's growth and strategic direction in a recent interview with CEO Monthly.

Since joining in 2022, Terry Petersen has focused on enhancing company culture, expanding the product portfolio, and driving operational excellence. With a clear five-year strategy in place, the company is poised for continued success in the pharmaceutical industry. Learn more about Kent-Athlone Pharma Group's plans and Petersen's leadership by reading the full interview.

Read the Full Interview
Date Published
September 4, 2024
Posted By
Kent-Athlone Pharma Group
Share Article
If you require general information concerning one of our products, including availability, please contact our customer services team: